Showing results (221-230 of 297) with videos related to

Sort By:
Pageof 30
The Journal of Rheumatology|February 12, 2010
Biomarkers in psoriasis and psoriatic arthritis: GRAPPA 2008Christopher T Ritchlin, Abrar A Qureshi, Kurt de Vlam, et al.
RMD Open|March 26, 2024
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled studyLaura C Coates, Laure Gossec, Miriam Zimmermann, et al.
Rheumatology and Therapy|April 25, 2024
Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European InitiativeIris Verbinnen, Emilio Monte-Boquet, Detlev Parow, et al.
RMD Open|September 28, 2022
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritisLaura C Coates, Josef S Smolen, Philip J Mease, et al.
Rheumatology (Oxford, England)|August 16, 2014
Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre studyWilliam Tillett, Gavin Shaddick, Ayman Askari, et al.
The Lancet. Rheumatology|September 6, 2025
Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trialGabriele De Marco, Elizabeth M A Hensor, Philip S Helliwell, et al.
Trials|February 12, 2020
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)Michelle L M Mulder, Johanna E Vriezekolk, Nathan den Broeder, et al.
Arthritis Research & Therapy|July 15, 2021
Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritisProton Rahman, Philip J Mease, Philip S Helliwell, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 27, 2018
Assessment of two screening tools to identify psoriatic arthritis in patients with psoriasisL C Coates, L J Savage, H Chinoy, et al.
Lancet (London, England)|March 18, 2020
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trialAtul Deodhar, Philip S Helliwell, Wolf-Henning Boehncke, et al.
Pageof 30